DK1079818T3 - Præparat omfattende IL-18 og topotecan til behandling og/eller forhindring af cancer - Google Patents

Præparat omfattende IL-18 og topotecan til behandling og/eller forhindring af cancer

Info

Publication number
DK1079818T3
DK1079818T3 DK99952068T DK99952068T DK1079818T3 DK 1079818 T3 DK1079818 T3 DK 1079818T3 DK 99952068 T DK99952068 T DK 99952068T DK 99952068 T DK99952068 T DK 99952068T DK 1079818 T3 DK1079818 T3 DK 1079818T3
Authority
DK
Denmark
Prior art keywords
topotecan
cancer
prevention
treatment
composition
Prior art date
Application number
DK99952068T
Other languages
Danish (da)
English (en)
Inventor
Randall K Johnson
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22199389&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1079818(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of DK1079818T3 publication Critical patent/DK1079818T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
DK99952068T 1998-05-21 1999-05-20 Præparat omfattende IL-18 og topotecan til behandling og/eller forhindring af cancer DK1079818T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8656098P 1998-05-21 1998-05-21

Publications (1)

Publication Number Publication Date
DK1079818T3 true DK1079818T3 (da) 2004-04-19

Family

ID=22199389

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99952068T DK1079818T3 (da) 1998-05-21 1999-05-20 Præparat omfattende IL-18 og topotecan til behandling og/eller forhindring af cancer

Country Status (28)

Country Link
US (1) US6582689B1 (zh)
EP (1) EP1079818B1 (zh)
JP (1) JP4283998B2 (zh)
KR (1) KR100624588B1 (zh)
CN (1) CN1227027C (zh)
AR (1) AR019844A1 (zh)
AT (1) ATE245440T1 (zh)
AU (1) AU750918B2 (zh)
BR (1) BR9910622A (zh)
CA (1) CA2328603A1 (zh)
CO (1) CO5050337A1 (zh)
CZ (1) CZ300496B6 (zh)
DE (1) DE69909781T2 (zh)
DK (1) DK1079818T3 (zh)
ES (1) ES2204164T3 (zh)
GC (1) GC0000102A (zh)
HK (1) HK1035136A1 (zh)
HU (1) HUP0600520A2 (zh)
IL (2) IL139733A0 (zh)
MY (1) MY123434A (zh)
NO (1) NO329195B1 (zh)
NZ (1) NZ508115A (zh)
PL (1) PL200840B1 (zh)
PT (1) PT1079818E (zh)
TR (1) TR200003453T2 (zh)
TW (1) TWI227136B (zh)
WO (1) WO1999059565A1 (zh)
ZA (1) ZA200006675B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2251610T3 (es) * 2001-03-08 2006-05-01 Ares Trading S.A. Mutantes de interleuquina-18, su produccion y su uso.
US20050079153A1 (en) * 2002-08-14 2005-04-14 Pfizer Inc. Methods for enhancing immune functions in neonatal mammals by administration of IL-18
WO2004031276A2 (en) * 2002-09-19 2004-04-15 Centocor, Inc. Method of inducing maturation of dendritic cells and uses therefor
ATE526057T1 (de) * 2004-08-20 2011-10-15 Glaxosmithkline Llc Wundheilung durch verabreichung von menschlichem il-18
WO2008033499A2 (en) * 2006-09-14 2008-03-20 The Trustees Of The University Of Pennsylvania Modulation of regulatory t cells by human il-18
AR065803A1 (es) * 2007-03-23 2009-07-01 Smithkline Beecham Corp Uso de un polipeptido de il- 18 humana y un anticuerpo anti- cd para preparar unmedicamento
GB0803352D0 (en) 2008-02-22 2008-04-02 Ntnu Technology Transfer As Oligopeptidic compounds and uses thereof
US8168165B2 (en) * 2008-12-23 2012-05-01 Abbott Laboratories Alkylated interleukin-18 compositions
TW201506402A (zh) * 2013-08-15 2015-02-16 Tonyar Biotech Inc 自體防潮的檢驗芯片及其製造方法
IL272635B2 (en) * 2017-09-06 2024-02-01 Univ Yale Variants of interleukin-18 and methods of use
WO2022094473A1 (en) 2020-11-02 2022-05-05 Simcha IL-18, Inc. Interleukin-18 variants and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
TW581771B (en) 1994-11-15 2004-04-01 Hayashibara Biochem Lab Recombinant production of a polypeptide for inducing interferon-gamma production, and monoclonal antibody against the polypeptide
JP4004088B2 (ja) 1995-09-26 2007-11-07 株式会社林原生物化学研究所 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質
US6207641B1 (en) * 1995-03-10 2001-03-27 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Pharmaceutical composition containing IFN-γ inducing polypeptide or factor for treating and/or preventing IFN-γ susceptive diseases
US5869535A (en) * 1995-03-21 1999-02-09 The Board Of Trustees Of The University Of Illinois Method and composition for selectively inhibiting melanoma
JP4024366B2 (ja) * 1996-11-29 2007-12-19 株式会社林原生物化学研究所 ポリペプチド

Also Published As

Publication number Publication date
KR20010052369A (ko) 2001-06-25
TR200003453T2 (tr) 2001-10-22
CZ300496B6 (cs) 2009-06-03
IL139733A0 (en) 2002-02-10
EP1079818B1 (en) 2003-07-23
ES2204164T3 (es) 2004-04-16
AR019844A1 (es) 2002-03-20
TWI227136B (en) 2005-02-01
IL139733A (en) 2009-06-15
NZ508115A (en) 2003-12-19
CZ20004321A3 (en) 2001-05-16
AU750918B2 (en) 2002-08-01
MY123434A (en) 2006-05-31
CN1367686A (zh) 2002-09-04
NO329195B1 (no) 2010-09-13
DE69909781D1 (de) 2003-08-28
US6582689B1 (en) 2003-06-24
DE69909781T2 (de) 2004-05-27
ZA200006675B (en) 2002-02-27
JP4283998B2 (ja) 2009-06-24
AU4309499A (en) 1999-12-06
CO5050337A1 (es) 2001-06-27
HUP0600520A2 (en) 2006-10-28
EP1079818A4 (en) 2001-12-12
NO20005857D0 (no) 2000-11-20
CN1227027C (zh) 2005-11-16
CA2328603A1 (en) 1999-11-25
JP2003509333A (ja) 2003-03-11
GC0000102A (en) 2005-06-29
BR9910622A (pt) 2001-01-30
HK1035136A1 (en) 2001-11-16
EP1079818A1 (en) 2001-03-07
PL366170A1 (en) 2005-01-24
PT1079818E (pt) 2004-02-27
PL200840B1 (pl) 2009-02-27
ATE245440T1 (de) 2003-08-15
WO1999059565A1 (en) 1999-11-25
NO20005857L (no) 2000-11-21
KR100624588B1 (ko) 2006-09-18

Similar Documents

Publication Publication Date Title
DK1123313T3 (da) Fremgangsmåder og sammensætninger til forebyggelse og behandling af anæmi
NO20024610D0 (no) Synergistiske metoder og blandinger for behandling av kreft
AU6147401A (en) Compositions and methods for the treatment of cancer
DK1109453T3 (da) Sammensætninger og fremgangsmåder til behandling af mitokondrielle sygdomme
NO994778D0 (no) FremgangsmÕter og sammensetninger for behandling av tarmbetennelse
NO20011613L (no) Sammensetninger og fremgangsmåte for WT1-spesifikk immunterapi
DK1032408T3 (da) Galenisk præparat til forebyggelse og behandling af leverkarcinom
DK2412368T3 (da) Sammensætning til behandling af ar
DK1003479T3 (da) Fremgangsmåde og sammensætninger til behandling af allergiske senfasereaktioner og inflammatoriske sygdomme
DE69836008D1 (de) Zusammensetzung und behandlungsmittel
NO20006488D0 (no) Sammensetning og anvendelse
HUP0104688A3 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
DK1278540T3 (da) Anvendelse af IL-18-inhibitorer til behandling og/eller forebyggelsen af aterosklerose
NO20015516L (no) Preparater og anvendelser av ET743 for behandling av kreft
NO20002189D0 (no) Anvendelse av makrolider for behandling av cancer og mukuladegenerasjon
DK1079818T3 (da) Præparat omfattende IL-18 og topotecan til behandling og/eller forhindring af cancer
NO994631D0 (no) Fremgangsmaater og sammensetninger for behandling av eggstokkreft
PL368035A1 (en) Compositions and methods for the treatment of cancer
NO20010464D0 (no) Fremgangsmåter og sammensetninger for behandling av gastroösofrageal-reflukssyndrom
IL143212A0 (en) Compositions and methods for the treatment of tumor
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
EE200300057A (et) Koostis vähi profülaktikaks ja raviks
IL147410A0 (en) L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases
AU2002366195A1 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer